Please assess the completion status of the following clinical trial:

Trial Title: Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of undifferentiated arthritis~* Clinical synovitis of two or more joints~* At least one but not more than three of the criteria for diagnosis of RA (1987).~* No prior disease modifying anti-rheumatic drugs (DMARDs)/biologics.~* Duration of disease must be 18 months or less.~* Positive for antibodies against cyclic citrullinated peptides.~Exclusion Criteria:~* Women of child bearing potential who are unwilling or unable to use an acceptable method to avoid pregnancy.~* Active vasculitis of a major organ system.~* Severe or recurrent bacterial infection.~* History of cancer in the last five years except certain skin cancers.~* Herpes zoster that resolved less than 2 months prior to enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).